BIOLASE Names Medical Device Marketing Veteran Orlando

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
BIOLASE Names Medical Device Marketing Veteran Orlando Rodrigues as Vice President, Marketing

IRVINE, CA--(Marketwired - Jul 23, 2013) - BIOLASE, Inc. ( NASDAQ : BIOL ), the world's leading manufacturer and distributor of dental lasers and a pioneer in laser surgery in other medical specialties, announced today that medical device marketing executive and eye care, medical laser, and post-surgical anesthesia industry veteran Orlando P. Rodrigues has been named Vice President, Marketing. Mr. Rodrigues will report to President and Chief Operating Officer Alexander K. Arrow, M.D.

Mr. Rodrigues, 51, was Vice President of Marketing for I-Flow Corporation from 2002-2010, during which time I-Flow revenues grew from $25 million to $140 million. Mr. Rodrigues created brand awareness and guerrilla marketing campaigns that motivated surgeons and anesthesiologists to adopt I-Flow's ON-Q post-surgical pain control product as the standard of care, and persuaded several hospitals and surgery centers to spend their own marketing funds on co-op ads to attract patients by showing that they offered I-Flow's products at their facility. By the time I-Flow was acquired by Kimberly Clark ( NYSE : KMB ) in November 2009 for $325 million, it had a sales force of some 300 people in 170 sales territories.

From 2000 to 2001, Mr. Rodrigues was VP of Marketing for Laser Diagnostic Technologies, Inc., a laser medical device company serving ophthalmologists and optometrists in single office and chain settings, a role that including marketing financing to office-based clinicians. "I'm excited to join BIOLASE ® , a company where dental and numerous non-dental market opportunities make it ideal to apply marketing practices that have been proven successful at linking disruptive platform technologies with practitioners who need them," said Mr. Rodrigues. "BIOLASE has fantastic dental products with significant benefits that have been under-marketed. I will work hard to see that our customers, prospective customers, and patients will enjoy a better surgical experience. Plus, we will add new campaigns to drive interest and demand in multiple non-dental markets."

Rodrigues began his career at Allergan, Inc. in 1983 and rose to the position of Director of Strategic Marketing. After a decade at Allergan, Rodrigues worked for the consumer-oriented Vision Care Division of Alcon Laboratories, Inc. as Group Product Director and eventually Director of Marketing. He then held the roles of VP, Marketing and VP, Consumer Development Division, at Sonic Innovations, Inc. (NASDAQ: SNCI).

Federico Pignatelli, Chairman and Chief Executive Officer, said, "I am pleased to have the talented and energetic Mr. Rodrigues take on the role of Vice President, Marketing. For the first time in five years, BIOLASE has separated the departments of Sales and Marketing - which is consistent with medical technology best practices for optimizing both departments. Our upcoming non-dental launches and our core dental business growth opportunities make this the right time to expand and deepen our management structure in this way."

"Our goal was to fill this position with someone who knows how to create marketing campaigns that persuade clinicians to get involved in marketing a company's product," said Alexander Arrow, MD, President and Chief Operating Officer. "The right person would also have worked with a product that required clinicians to change their habits to use it, and have also led marketing for a company whose product was capital equipment, preferably involving lasers. Orlando meets both those criteria, plus he is a known quantity to me because I have followed his work for eleven years. I always thought that if I ever had the opportunity to hire Orlando to head marketing in a company, I would do it."

About BIOLASE, Inc. BIOLASE, Inc. is a biomedical company that develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment and CAD/CAM intraoral scanners; products that are focused on technologies that advance the practice of dentistry and medicine . The Company's proprietary laser products incorporate over 350 patented and patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its imaginative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold more than 22,500 lasers. Other laser products under development address ophthalmology and other medical and consumer markets.

For updates and information on WaterLase ® and laser dentistry, find BIOLASE online at www.biolase.com , Facebook at www.facebook.com/biolaseinc , Twitter at www.twitter.com/biolaseinc , Pinterest at www.pinterest.com/biolase , LinkedIn at www.linkedin.com/company/biolase , Instagram at www.instagram.com/biolaseinc and YouTube at www.youtube.com/biolasevideos .

BIOLASE ® and WaterLase ® are registered trademarks of BIOLASE, Inc.

For further information, please contact: Michael Porter Porter, LeVay & Rose, Inc. 212-564-4700

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nomada Fund Launches: A Game-Changer in New Media

Updated Category News Views 8

Changing the Investment Game In a world where tech isn't the only kingmaker, distribution is the new play. Welcome the Nomada Fund, a fresh face on the investment scene that's swapping cash for exposure. Forget the traditional media-for-equity model that only old-timers still drool over—these guys are taking it up a notch with their new Distribution for Equity approach,...

Continue Reading
Chicago Scenic Studios’ Equipment Up for Grabs in Auction

Updated Category News Views 10

A Peek into the Sale: What's on the Block? Get that coffee brewing and settle in, because we've got to unpack some interesting stuff happening with Chicago Scenic Studios. This isn't just any Craigslist decampment—Integra Asset Solutions is rolling out an online auction come October 27 that’ll have equipment-savvy investors’ ears perking up like they just snagged a...

Continue Reading
Solvang Teamsters Triumph in Labor Standoff

Updated Category News Views 2

Solvang Strikers Prevail with New Deal Staring down the barrel of a five-week standoff, the hard-nosed workers of Solvang just proved exactly what grit can get you. The City of Solvang and the steadfast members of Teamsters Local 986 wrapped up their punchy back-and-forth by clinching a contract that ups the ante on wages and job respect. For a bunch who stuck it out on...

Continue Reading
Navigating AI Laws: A New Era for Privacy & Security

Updated Category News Views 0

Crucial Insights from the Convergence Conference Rich with intrigue, the privacy and AI governance game just upped its stakes. If there ever was a time to listen closely, it's now, people. With over 150 laws sprouting up faster than weeds, businesses are getting squeezed to keep their artificial ducks in a row. Last month over in New York, some big names in law and...

Continue Reading
Clean Power Alliance's Bond Deal Secures $91M Savings

Updated Category News Views 3

CPA Triumphs Yet Again With Bond Savings I'll tell you, the Clean Power Alliance (CPA) just hit the jackpot again. We're talking a $1.4 billion energy prepayment bond deal that locks in a whopping $91.1 million in savings over the next seven years. Not bad, huh? A Closer Look at the Numbers CPA's charm—besides being the top green power supplier in the U.S.—is spinning...

Continue Reading
Cancer Memoir Shows Healing Beyond Medicine

Updated Category News Views 5

Confronting the Unfathomable Out of the North Carolina mountains comes a story that defies expectations—a pastor and farmer named Mark Heisey, who faced the no-holds-barred trials of stage IV-B lymphoma. Now, I'll shoot you straight: this isn't your run-of-the-mill self-help guide or a clinical breakdown of battling cancer. His new memoir dives into the personal and...

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 4

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
Venue Two Eleven: Historic Charm Meets Modern Events

Updated Category News Views 7

Welcome To Venue Two Eleven: Where History Meets Modernity Alright, folks. Let’s talk about Venue Two Eleven—a new joint in town that’s blending the old with the new in a way that’s got me raising an eyebrow and maybe even sipping my coffee a little slower. Nestled in the Museum of the Oregon Territory, this place is pulling double duty as both a window to the...

Continue Reading
Tenant Improvement: Key to Adapting Lease Spaces

Updated Category News Views 1

Adapting Space or Adapting Business? Here's the thing that keeps popping up in commercial real estate: tenant improvement construction. This isn't just modifying a structure—it's about rethinking how businesses operate within a certain space. The HelloNation article gives you the lowdown straight from Bradley Quakenbush of White Oak Commercial Group. When businesses...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 47

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading

Top 5 Most Recently Viewed Articles

Cartesian Therapeutics Unveils Incentive Awards for New Employees

Updated Category News Views 45

Cartesian Therapeutics Enhances Workforce with Inducement Grants In an exciting development, Cartesian Therapeutics, Inc. (NASDAQ: RNAC), a prominent clinical-stage biotechnology firm, has made significant strides in expanding its workforce by announcing the granting of inducement awards to five new employees. This move underscores the company's commitment to attracting...

Continue Reading
Concerns Rise as Archer Health Faces Investigation Over Patient Data

Updated Category News Views 323

Archer Health Under Investigation for Patient Data Breach Archer Health, Inc., a provider of in-home healthcare services, is facing serious scrutiny after a significant data breach involving unauthorized access to sensitive patient records. The investigations are being led by Schubert Jonckheer & Kolbe LLP, which aims to provide clarity and assistance to those affected....

Continue Reading
ATEN's Networked AV Series Shines with Innovative Award Win

Updated Category News Views 229

ATEN's Award-Winning Networked AV Series Excellence ATEN International, a distinguished provider of AV/IT connectivity and management solutions, proudly announces its Networked AV Series has been awarded the esteemed Good Design Award for 2024. This recognition highlights the system's user-friendliness and its ability to deliver high-quality audio-visual (AV) transmission...

Continue Reading
Paul Vallis Takes Charge as CEO of Lubrication Engineers

Updated Category News Views 102

Paul Vallis Appointed as CEO of Lubrication Engineers Lubrication Engineers (LE), a prominent player in high-performance industrial lubricants and asset reliability solutions, recently announced the appointment of Paul Vallis as their new Chief Executive Officer. This decision marks a transformative moment for LE, which has seen remarkable growth and expansion, including...

Continue Reading
Two Seas Capital's Vision for Core Scientific's Future Growth

Updated Category News Views 132

Two Seas Capital Responds to Special Meeting Results Two Seas Capital LP, a notable alternative investment management firm, has expressed gratitude towards Core Scientific shareholders following the recent special meeting regarding the proposed sale to CoreWeave. With a commitment to transparency and effective communication, Two Seas reinforces its optimism about Core...

Continue Reading